1. The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan

   • Kuniko Sunami
   • Yoichi Naito
   • Takayuki Yoshino

   Special Article Open access 01 January 2021 Pages: 443 - 449

2. Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis

   • Pipit Burasakarn
   • Ryota Higuchi
   • Japan Duodenal Cancer Guideline Committee

   Review Article 01 January 2021 Pages: 450 - 460

   

3. Cryoablation, high-intensity focused ultrasound, irreversible electroporation, and vascular-targeted photodynamic therapy for prostate cancer: a systemic review and meta-analysis

   • Run-Qi Guo
   • Xiao-Xiao Guo
   • Xiao-Guang Li

   Review Article 02 January 2021 Pages: 461 - 484

   

4. Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan

   • Shohei Nakamura
   • Yusuke Kanemasa
   • Akifumi Imamura

   Original Article 23 November 2020 Pages: 485 - 493

   

5. Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study

   • Nobuhiro Hanai
   • Yasushi Shimizu
   • Akihiro Homma

   Original Article Open access 21 November 2020 Pages: 494 - 506

   

6. Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer

   • Tsukasa Hasegawa
   • Noriko Yanagitani
   • Makoto Nishio

   Original Article 07 November 2020 Pages: 507 - 514

   

7. Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302

   • Yosuke Kawashima
   • Toshiyuki Harada
   • Shunichi Sugawara

   Original Article 13 November 2020 Pages: 515 - 522

   

8. Association between skeletal muscle loss and the response to nivolumab immunotherapy in advanced gastric cancer patients

   • Mikihiro Kano
   • Jun Hihara
   • Shinya Takahashi

   Original Article 23 November 2020 Pages: 523 - 531

   

9. TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway

   • Guosheng Tan
   • Binhui Xie
   • Heping Li

   Original Article 02 January 2021 Pages: 532 - 542

   

10. Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patients

    • Tsuyoshi Takeda
    • Takashi Sasaki
    • Naoki Sasahira

    Original Article 11 November 2020 Pages: 543 - 551

    

11. Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma

    • Yudai Ishiyama
    • Tsunenori Kondo
    • Kazunari Tanabe

    Original Article 01 November 2020 Pages: 552 - 561

    

12. Oncologic outcomes and safety of percutaneous cryoablation for biopsy-proven renal cell carcinoma up to 4 cm in diameter: a prospective observational study

    • Hideo Gobara
    • Takao Hiraki
    • Susumu Kanazawa

    Original Article 10 November 2020 Pages: 562 - 568

13. The metabolic syndrome is associated with the risk of urothelial carcinoma from a health examination database

    • Hsiang-Ying Lee
    • Jia-Hong Tang
    • Ta-Chien Chan

    Original Article 24 November 2020 Pages: 569 - 577

14. Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial

    • Hiroji Uemura
    • Hisashi Matsushima
    • Kazuhiro Suzuki

    Original Article Open access 23 November 2020 Pages: 578 - 590

    

15. The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model

    • Masahiro Kagabu
    • Naoto Yoshino
    • Toru Sugiyama

    Original Article 04 November 2020 Pages: 591 - 597

    

16. Bevacizumab-associated events in Japanese women with cervical cancer: a multi-institutional survey of Obstetrical Gynecological Society of Kinki district, Japan

    • Seiji Mabuchi
    • Misa Yamamoto
    • Sho Matsubara

    Original Article 13 November 2020 Pages: 598 - 605

17. Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients

    • Yuki Saito
    • Hiroki Fujikawa
    • Tatsuya Takenouchi

    Original Article 11 November 2020 Pages: 606 - 612

    

18. Diagnostic accuracies of intraoperative frozen section and permanent section examinations for histological grades during open biopsy of bone tumors

    • Shinji Miwa
    • Norio Yamamoto
    • Hiroyuki Tsuchiya

    Original Article 23 November 2020 Pages: 613 - 619

    

19. Is it a case series? Comment on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”

    • Min Luo
    • Yetao Li

    Letter to the Editor 01 January 2021 Pages: 620 - 620

20. Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”

    • Sakura Hiraide
    • Keigo Komine
    • Chikashi Ishioka

    Letter to the Editor Open access 06 February 2021 Pages: 621 - 621